TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT01695772

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 5-FU based doublet chemotherapy
Description: Standard 5-FU based doublet chemotherapy. Protocol did not specify any particular chemotherapy regimen. The choice of 5-FU based doublet chemotherapy was as per standard of practice and the dosage of 5-FU based doublet chemotherapy was as per product labels.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: bevacizumab
Description: 5 mg/kg every 2 weeks, up to 12 cycles pre- and postoperatively
Study: NCT03511846

Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Oral capsaicin
Description: Subjects will drink a solution with capsaicin

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Topical capsaicin
Description: Capsaicin cream will be applied to the skin of the forehead, cheek, or leg
Study: NCT04461821

Intervention type: DIAGNOSTIC_TEST
Intervention: Off-line breath analysis
Description: In young children below the age of 4 not capable of completing the on-line exhalation maneuvers, or in cases when the patient needs cannot approach the mass spectrometer, the sample will be collected off-line. They will be asked to exhale into a bag that will be transported to the lab and deflated into the mass spectrometer for analysis. Exhaled breath of patients under anesthesia will also collected using available ventilation system in the operation theatre.
Study: NCT03511846

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Topical capsaicin
Description: Capsaicin cream will be applied to the skin of the forehead, cheek, or leg

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Topical capsaicin
Description: Capsaicin cream will be applied to the skin of the forehead, cheek, or leg

Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Topical capsaicin
Description: Capsaicin cream will be applied to the skin of the forehead, cheek, or leg

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Intranasal capsaicin
Description: Capsaicin cream will be applied to the nostril

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Intranasal capsaicin
Description: Capsaicin cream will be applied to the nostril
Study: NCT03511846

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Intranasal capsaicin
Description: Capsaicin cream will be applied to the nostril
Study: NCT04461821

Intervention type: DIAGNOSTIC_TEST
Intervention: Blood analysis
Description: Blood analysis done in patients who undergo regular blood sampling needed for clinical routine laboratory controls. This includes i) children and adolescents receiving medications which require TDM ii) patients with acute diseases such as TD1 and pneumonia and iii) patients with chronic diseases such as asthma bronchiale. For those patients where a blood sample is drawn during the clinical routine, an additional blood sample consisting of only several blood drops will be collected using the same blood sampling line. No additional venous puncture for research purpose will be done.

Intervention type: DIAGNOSTIC_TEST
Intervention: Blood analysis
Description: Blood analysis done in patients who undergo regular blood sampling needed for clinical routine laboratory controls. This includes i) children and adolescents receiving medications which require TDM ii) patients with acute diseases such as TD1 and pneumonia and iii) patients with chronic diseases such as asthma bronchiale. For those patients where a blood sample is drawn during the clinical routine, an additional blood sample consisting of only several blood drops will be collected using the same blood sampling line. No additional venous puncture for research purpose will be done.
Study: NCT03511846

Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Intranasal capsaicin
Description: Capsaicin cream will be applied to the nostril
Study: NCT01701310

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ferric carboxymaltose
Description: A minimum of 1 dose of 1000mg of intravenous ferric carboxymaltose will be administered at least 14 days prior to the date of operation.
Study: NCT03511846

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cold Water Irrigation
Description: Subjects will be asked to drink up to 2000 ml of cold water or ice water (temperature 0-10 degrees Celsius) as fast as possible, either continuously or intermittently (i.e. 200-800 ml at a time)
Study: NCT04461821

Intervention type: DIAGNOSTIC_TEST
Intervention: Blood analysis
Description: Blood analysis done in patients who undergo regular blood sampling needed for clinical routine laboratory controls. This includes i) children and adolescents receiving medications which require TDM ii) patients with acute diseases such as TD1 and pneumonia and iii) patients with chronic diseases such as asthma bronchiale. For those patients where a blood sample is drawn during the clinical routine, an additional blood sample consisting of only several blood drops will be collected using the same blood sampling line. No additional venous puncture for research purpose will be done.
Study: NCT01701310

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ferrous Sulphate
Description: (Control) 200mg twice a day of oral ferrous sulphate will be administered for a minimum of a two week period
Study: NCT00951821

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Concurrent treatment
Description: Individual CBT sessions for parents and adolescents plus combined parent-adolescent family sessions, delivered weekly for 3 months in the acute phase and bimonthly for 3 months in the maintenance phase. The techniques used to teach cognitive restructuring and problem solving to parents will be similar to those taught to the adolescents, except emotion regulation skills will be added to the parent treatment.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Adolescent treatment only
Description: Individual CBT for adolescents only plus combined parent-adolescent family sessions, delivered weekly for 3 months in the acute phase and bimonthly for 3 months in the maintenance phase
Study: NCT01268293

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: E7080
Description: This arm will be a dose-escalation evaluation of 9-18 subjects to investigate the tolerability and safety of E7080 up to 24 mg when administered orally on a once daily continuous dose schedule in cycles (4 weeks as 1 cycle). Administration of the study drug can continue until subjects meet discontinuation criteria such as disease progression, intolerable toxicity, and withdrawal of study consent.
Study: NCT00716976

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: sodium thiosulfate
Description: Given IV

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: examination
Description: Patients undergo audiological assessments periodically

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: examination
Description: Patients undergo audiological assessments periodically
Study: NCT02804763

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Solution for infusion, 0,9% saline

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dapirolizumab pegol (DZP)
Description: Solution for infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dapirolizumab pegol (DZP)
Description: Solution for infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dapirolizumab pegol (DZP)
Description: Solution for infusion
Study: NCT00067756

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 4-PBA
Description: During the first 3 days of this phase baseline serum AAT levels will be determined. The participants will be then given increased amounts of 4-PBA orally in 6 divided doses (day 4-6, 30 g/day and day 7-9, 40/day
Study: NCT02181933

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nevirapine

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Zidovudine (ZDV)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lamivudine (3TC)
Study: NCT02599584

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: precritical staff
Description: free pre critical scenario team staff
Study: NCT04858893

Intervention type: DIAGNOSTIC_TEST
Intervention: CoMDA associated with Neural Net 91 classificator

Intervention type: DIAGNOSTIC_TEST
Intervention: CoMDA associated with Neural Net 91 classificator
Study: NCT01915316

Intervention type: OTHER
Intervention: prostate biopsy
Description: Measurements of Zinc concentration along fresh Specimens taken during Trans-Perineal saturated repeat Prostate Biopsy before Specimens are sent to Pathology.
Study: NCT03511846

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cold Water Irrigation
Description: Subjects will be asked to drink up to 2000 ml of cold water or ice water (temperature 0-10 degrees Celsius) as fast as possible, either continuously or intermittently (i.e. 200-800 ml at a time)

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cold Water Irrigation
Description: Subjects will be asked to drink up to 2000 ml of cold water or ice water (temperature 0-10 degrees Celsius) as fast as possible, either continuously or intermittently (i.e. 200-800 ml at a time)
Study: NCT00959751

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NXN-188
Description: 200 mg capsules, 600 mg, PRN
Study: NCT00883883

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cefdinir 250 mg/5 ml Suspension (Sandoz, Austria)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Omnicef Cefdinir 250 mg/5 ml Suspension (Abbott Laboratories, USA)
Study: NCT00959751

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 200 mg capsules with no active ingredient designed to match the NXN-188 capsules
Study: NCT03511846

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Cold Water Irrigation
Description: Subjects will be asked to drink up to 2000 ml of cold water or ice water (temperature 0-10 degrees Celsius) as fast as possible, either continuously or intermittently (i.e. 200-800 ml at a time)

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Medical Air
Description: Subjects will be exposed to medical air
Study: NCT01554787

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chinese Herb Astragalus membranaceus
Description: Astragalus membranaceus(AM)at a rate of 2.8g three times per day

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: at a rate of 2.8g three times per day
Study: NCT03511846

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Medical Air
Description: Subjects will be exposed to medical air

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Medical Air
Description: Subjects will be exposed to medical air

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Medical Air
Description: Subjects will be exposed to medical air

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Low Flow Oxygen
Description: Subjects will be exposed to oxygen gas between 1-9 L/min

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Low Flow Oxygen
Description: Subjects will be exposed to oxygen gas between 1-9 L/min

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Low Flow Oxygen
Description: Subjects will be exposed to oxygen gas between 1-9 L/min
Study: NCT05446493

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tadalafil 5mg
Description: * Estimate serum level of serum YKL-40, total testosterone and platelets indices in diabetic patients with erectile dysfunction treated by daily tadalafil 5mg for 3months.~* Penile color Doppler ultrasound examination before and after treatment
Study: NCT03511846

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Low Flow Oxygen
Description: Subjects will be exposed to oxygen gas between 1-9 L/min

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: High Flow Oxygen
Description: Subjects will be exposed to oxygen gas between 10-25 L/min

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: High Flow Oxygen
Description: Subjects will be exposed to oxygen gas between 10-25 L/min

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: High Flow Oxygen
Description: Subjects will be exposed to oxygen gas between 10-25 L/min

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: High Flow Oxygen
Description: Subjects will be exposed to oxygen gas between 10-25 L/min
Study: NCT04291261

Intervention type: DRUG
Group type: OTHER
Intervention: Uvadex
Description: Extracorporeal photopheresis (ECP) with Uvadex is scheduled 3x/week in weeks 1+2, 2x/week thereafter till day 28 and 1x/week till day 56
Study: NCT04544722

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Jianfei Kangfu Cao
Description: The original treatment and Jianfei Kangfu Cao, once a day, 30 minutes each time.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: lung rehabilitation training
Description: The original treatment and the lung rehabilitation training, once a day, 30 minutes each time.
Study: NCT02681666

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Dietary intervention
Description: Sessions will be spent with patients discussing the FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides, and polyols) diet and how to use this diet to treat their Irritable Bowel Syndrome.
Study: NCT03059368

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: new bone fixation plate with screw
Description: Fracture ends and injured posterior cruciate ligament will be exposed in twenty patients with tibial avulsion fracture of posterior cruciate ligament of knee through posterior approach. Open reduction will be conducted. The posterior cruciate ligament will be reconstructed with a new bone fixation plate with screw(cancellous bone screw).
Study: NCT00879177

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Varenicline
Description: Varenicline: 1 tab 0.5mg once a day for 3 days; 1 tab 0.5mg twice a day for 4 days; followed by 1 tab 1mg twice a day for 11 weeks.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Varenicline
Description: Varenicline: 1 tab 0.5mg once a day for 3 days; 1 tab 0.5mg twice a day for 4 days; followed by 1 tab 1mg twice a day for 11 weeks.
Study: NCT02857088

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: olfactory assessment
Description: determination of olfactory sensitivity through olfactory threshold assessment (butanol) determination of hedonicity and intensity of 16 usual odors

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: olfactory assessment
Description: determination of olfactory sensitivity through olfactory threshold assessment (butanol) determination of hedonicity and intensity of 16 usual odors

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: image visualization
Description: 20 images (from the IAPS-international affective picture systems) are presented to the subject. He has to determine the hedonicity of each picture.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: image visualization
Description: 20 images (from the IAPS-international affective picture systems) are presented to the subject. He has to determine the hedonicity of each picture.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: psychophysiological assessment
Description: during the olfaction assessment and the image visualization, skin conductance reactivity (SCR) is recorded to assess unconscious emotional reactivity

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: psychophysiological assessment
Description: during the olfaction assessment and the image visualization, skin conductance reactivity (SCR) is recorded to assess unconscious emotional reactivity
Study: NCT03100149

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RO7046015
Description: RO7046015 will be administered at dose of 4500 milligrams (mg) for participants with body-weight greater than or equal to (\>/=) 65 kilograms (kg) or 3500 mg for participants with body-weight less than (\<) 65 kg.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RO7046015
Description: RO7046015 will be administered at dose of 4500 milligrams (mg) for participants with body-weight greater than or equal to (\>/=) 65 kilograms (kg) or 3500 mg for participants with body-weight less than (\<) 65 kg.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RO7046015
Description: RO7046015 will be administered at dose of 1500 mg to all participants in the indicated arm.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RO7046015
Description: RO7046015 will be administered at dose of 1500 mg to all participants in the indicated arm.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RO7046015
Description: RO7046015 will be administered at dose of 1500 mg to all participants in the indicated arm.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: RO7046015 placebo will be administered to all participants in the indicated arm.
Study: NCT01464970

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Both Superficial Inferior Artery and Vein Clamped
Description: Perfusion assessed in Zone IV of the DIEP flap whilst both the contralateral Superficial Inferior Epigastric Artery and Vein are clamped

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Superficial Inferior Epigastric Vessels both unclamped
Description: Perfusion assessed in Zone IV of the DIEP flap whilst both the contralateral Superficial Inferior Epigastric Artery and Vein are unclamped
Study: NCT02681666

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Irritable Bowel Syndrome eating awareness training
Description: A type of meditation about their eating habits.
Study: NCT00879177

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: behavioral therapy
Description: confirmed negative smoking status at different time points
Study: NCT04818775

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: HemaClear
Description: HemaClear Model A
Study: NCT01501903

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Standard
Description: FNA in a single plane

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Fanning
Description: FNA in multiple planes
Study: NCT04818775

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Pneumatic Tourniquet
Description: Pneumatic Tourniquet
Study: NCT02512458

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cabazitaxel
Study: NCT02441647

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: KL029 Intimate Lubricant Gel
Study: NCT00878865

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Alprazolam
Description: 1 mg tablet one oral dose

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Alprazolam
Description: 1 mg tablet
Study: NCT01647178

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: TORQ assisted sternal closure

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional closure
Study: NCT02382302

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Telemedicine system
Description: The data such as photographs can be collected simply using built-in cameras installed in smart-phones that used the standard touch-screen user interface (UI) and camera installed in the iPhone3GS and iPhone4 using iOS 3.0 and iOS 5.0, respectively. Subjects were instructed to transmit the photographs of the wounds then investigator performed the photography in such a manner that the size of pressure ulcer should be automatically measured based on a 1 cm x 1 cm-sized indicator on the screen.
Study: NCT02807259

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Multi-level intervention
Description: At the individual level, the intervention will focus on: (i) structured reflection groups for FSWs to enhance self-esteem, encourage critical reflection around gender norms and violence, and build individual and collective efficacy; (ii) separate sessions for intimate partners to discuss issues around violence and condom use as well as gender, equity, respect and responsibility; (iii) skills building around female condoms (iv) access to individual and couples-based counselling. At the community level, the intervention will focus on: (i) strengthening the supportive crisis management systems so that they are able to address 'domestic' as well as 'work-place' violence among FSWs and (ii) building an environment that encourages action against violence from intimate partners by training male champions and developing folk media troops to generate discussion around gender, masculinity, violence and HIV risk behaviours.
Study: NCT01464970

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: SIE Artery Unclamped, Vein Clamped
Description: Perfusion assessed in Zone IV of the DIEP flap whilst the contralateral Superficial Inferior Epigastric Artery is unclamped and the Vein is clamped

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: SIE Artery clamped, Vein unclamped
Description: Perfusion assessed in Zone IV of the DIEP flap whilst the contralateral Superficial Inferior Epigastric Artery is clamped and the Vein is unclamped
Study: NCT02807259

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Multi-level intervention
Description: At the individual level, the intervention will focus on: (i) structured reflection groups for FSWs to enhance self-esteem, encourage critical reflection around gender norms and violence, and build individual and collective efficacy; (ii) separate sessions for intimate partners to discuss issues around violence and condom use as well as gender, equity, respect and responsibility; (iii) skills building around female condoms (iv) access to individual and couples-based counselling. At the community level, the intervention will focus on: (i) strengthening the supportive crisis management systems so that they are able to address 'domestic' as well as 'work-place' violence among FSWs and (ii) building an environment that encourages action against violence from intimate partners by training male champions and developing folk media troops to generate discussion around gender, masculinity, violence and HIV risk behaviours.
Study: NCT00714818

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Genetic Counseling
Description: One face-to-face genetic counseling session of 1-2hours duration, with a board certified or board eligible genetic counselor which will involve, documentation of a detailed family history, discussion of: the contributors to mental illness pathogenesis, illness risk reduction strategies, chances for family members to develop mental illness (if required), supportive counseling around living with illness/risk of illness/managing illness vulnerability, and referral to support organizations as required

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Genetic Counseling
Description: One educational booklet that provides information about the causes of mental illnesses, and the chances for relatives of affected individuals to develop mental illness will be provided to participants.
Study: NCT02332707

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Grazoprevir
Description: One GZR 100 mg tablet (Part A), or 2 FDC tablets containing GZR 50 mg per tablet (Part B), taken q.d.by mouth.